Calamos Advisors’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Calamos Advisors’s Portfolio HAIAW Stock Details HAIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500,000	Closed	-$13.7K	–	978
2024 Q3	$13.7K	Hold	500,000	–	–	﹤0.01%	864
2024 Q2	$26.2K	Hold	500,000	–	–	﹤0.01%	844
2024 Q1	$21.9K	Hold	500,000	–	–	﹤0.01%	851
2023 Q4	$12.6K	Hold	500,000	–	–	﹤0.01%	833
2023 Q3	$22K	Hold	500,000	–	–	﹤0.01%	818
2023 Q2	$34.8K	Hold	500,000	–	–	﹤0.01%	836
2023 Q1	$68.2K	Hold	500,000	–	–	﹤0.01%	913
2022 Q4	$29K	Buy	+500,000	New	+$32K	﹤0.01%	1014

Other funds holding HAIAW

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Calamos Advisors's HAIAW Position: Q4 2024 in Review

Calamos Advisors sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2024, closing a stake of 500,000 shares — an estimated $13.7K sold.

Calamos Advisors first reported a position in HAIAW in Q4 2022 and held it in 8 quarters. The position peaked at $68.2K in Q1 2023. 3 funds tracked by Wall St. Rank hold HAIAW as of Q4 2024.

Calamos Advisors reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2024 after selling out during the quarter.
Calamos Advisors sold 500,000 Healthcare AI Acquisition Corp. Warrants shares in Q4 2024, an estimated $13.7K.
Calamos Advisors first reported a position in Healthcare AI Acquisition Corp. Warrants in Q4 2022 and held it in 8 quarters.
Calamos Advisors's Healthcare AI Acquisition Corp. Warrants position peaked at $68.2K in Q1 2023.
3 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2024.

Based on Calamos Advisors's 13F filing for Q4 2024, filed 24 Jan 2025.